Other
Defined Benefit Plan, Expected Future Prescription Drug Subsidy Receipt, Year Three
Caterpillar Defined Benefit Plan, Expected Future Prescription Drug Subsidy Receipt, Year Three remained flat by 0.0% to $5.00M in Q4 2025 compared to the prior quarter. Over 2 years (FY 2023 to FY 2025), Defined Benefit Plan, Expected Future Prescription Drug Subsidy Receipt, Year Three shows relatively stable performance with a 0.0% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementBalance Sheet Statement
SectionOther
CategoryEfficiency
SignalHigher is better
VolatilityStable
First reportedQ4 2023
Last reportedQ4 2025Feb 13, 2026
How to read this metric
Stable or growing receipts indicate predictable offsets to long-term benefit expenses.
Detailed definition
This represents the expected cash inflows from government subsidies related to prescription drug benefits provided under...
Peer comparison
Standard disclosure for companies with significant legacy retiree healthcare liabilities.
Metric ID:
other_prescription_drug_subsidy_receipts_year_three1Historical Data
3 periods
| Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|
| Value | $5.00M | $5.00M | $5.00M |
| QoQ Change | — | +0.0% | +0.0% |
| YoY Change | — | +0.0% | +0.0% |
Range$5.00M – $5.00M
Avg YoY Growth+0.0%
Median YoY Growth+0.0%
Current Streak2+ quarters growth
Defined Benefit Plan, Expected Future Prescription Drug Subsidy Receipt, Year Three at Other Companies
Frequently Asked Questions
- What is Caterpillar's defined benefit plan, expected future prescription drug subsidy receipt, year three?
- Caterpillar (CAT) reported defined benefit plan, expected future prescription drug subsidy receipt, year three of $5.00M in Q4 2025.
- What is the long-term trend for Caterpillar's defined benefit plan, expected future prescription drug subsidy receipt, year three?
- Over 2 years (2023 to 2025), Caterpillar's defined benefit plan, expected future prescription drug subsidy receipt, year three has grown at a 0.0% compound annual growth rate (CAGR), from $5.00M to $5.00M.
- What does defined benefit plan, expected future prescription drug subsidy receipt, year three mean?
- Expected government payments for retiree prescription drug costs in the third year.